BioSpace News Archive

Drug Development

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company’s ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chronic oral treatment of primary mitochondrial disease.

December 20, 2019
·
4 min read
Business

Bioclinica Announces Senior Leadership Change

Bioclinica, a leading provider of clinical science and technology expertise to assist the life science industry, today announces that David Herron, Bioclinica’s President and Chief Executive Officer, will be leaving the company to pursue other business interests.

December 20, 2019
·
1 min read
FDA

NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO®)

NewLink Genetics Corporation (NASDAQ:NLNK) announced today that, after priority review, the FDA has granted approval of ERVEBO®, or Zaire Ebola virus vaccine V920 (rVSV∆G-ZEBOV-GP), as confirmed by our partner, Merck (NYSE:MRK), known as MSD outside the US and Canada.

December 20, 2019
·
5 min read
Business

Three Invacare Board Members Recognized by WomenInc. as Most Influential Corporate Directors

Invacare Corporation (NYSE: IVC) announced today that three members of its Board of Directors have been named to WomenInc. Magazine’s list of 2019 Most Influential Corporate Directors.

December 20, 2019
·
4 min read
BioForest

Global Anti-counterfeit Pharmaceutical Packaging Market to Surpass 7128.7 Million Units by 2027 – Coherent Market Insights

The global Anti-counterfeit pharmaceutical packaging market accounts for 2450.4 Million Units in terms of volume by the end of 2018 and is estimated to grow with a CAGR of 12.7% by 2027.

December 20, 2019
·
4 min read
Genetown

VA Boston to Receive Spinal Cord Rehabilitation Exoskeleton from SoldierStrong: Veteran Warriors Walk Again

SoldierStrong, a national nonprofit organization dedicated to providing revolutionary medical technologies to help injured Veterans lead full lives donating an Indego Therapy exoskeleton to VA Boston Healthcare System, West Roxbury Campus today.

December 20, 2019
·
2 min read
Drug Development

Longeveron LLC Announces Completion of Enrollment in Phase 1 Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cells (LMSCs) in Alzheimer’s Disease.

Longeveron LLC, a leading developer of adult stem cell technologies for chronic, aging-related and life-threatening conditions, announced today that it has completed enrollment in its Phase 1 Alzheimer’s disease trial

December 20, 2019
·
2 min read
Job Trends

United Health Products Issues Progress Report

United Health Products (UHP) (OTCPK: UEEC) today announced that 2019 was a pivotal year for the company in which it:

December 20, 2019
·
6 min read
Biotech Beach

OncoSec Responds to Alpha’s “Proposal”

OncoSec Medical Incorporated (NASDAQ:ONCS), (the “Company” or “OncoSec”) today issued the following response to the latest press release from Alpha Holdings, Inc. (Alpha):

December 20, 2019
·
7 min read
BioCapital

HeadFirst Concussion Care Offers Six Important Tips for Managing Holiday Season Stresses

The medical providers at HeadFirst Sports Injury and Concussion Care, the premier community concussion clinic for the diagnosis, management, and treatment of mild traumatic brain injuries (TBI), are offering tips for getting through the holidays while recovering from a head injury.

December 20, 2019
·
3 min read